Real-time enrollment status for this diffuse large b-cell lymphoma (dlbcl) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:46 PM UTC
| NCT Number | NCT07654426 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-cell Lymphoma (DLBCL) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Beth Israel Deaconess Medical Center |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 27, 2026: Clinical trial NCT07654426 is currently recruiting participants. This phase2 study for diffuse large b-cell lymphoma (dlbcl) is actively seeking new participants at 1 location across the United States. The study is sponsored by Beth Israel Deaconess Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07654426 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07654426 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.